1.
Use the EBM Principles and Methods to Improve the Quality of New Drug Approval in China
借鉴循证医学理念方法,提高我国新药审评质量
2.
CMC review of veregen and its enlightenment to the quality control of new Chinese herbal medicine
Veregen的药学审评对中药新药质量控制研究的启示
3.
The Application Research of Pharmacoeconomic Evaluation in New Chinese Traditional Patent Medicine Pre-market Evaluation
药物经济学评价在中成药新药上市评审中的应用研究
4.
An Analysis of FDA Botanical Drug Policy in the Context of VeregenTM Labeling;
从VEREGEN~(TM)的商品说明书内容看FDA植物新药评审的思路与要求
5.
National Committee on the assessment of protected traditional Chinese medicinal products
国家中药品种保护审评委员会
6.
The Basic Bio-evaluation Principles for Pesticide Registration;
农药登记的生物学资料评审基本原则
7.
Connecting and Perfecting the Regulations on Medical Patent Investigation and Registration;
药品专利审查和新药注册制度的链接与完善
8.
A New Exploration of Aesthetic Phenomena;
审美现象新探——兼评关于审美现象的若干说法
9.
Evaluation and Control on Data Auditing Risk Under New Auditing Standards;
新审计准则下的数据式审计风险评估与控制
10.
A New Probe into Auditing History in Zhou Dynasty and Han Dynasty--A Concurrent Review on Volume 1 of China s Auditing History;
周、汉审计史新议——兼评《中国审计史》第一卷
11.
On the Construction of China s Medicine Evaluation Advisory Committee Systems;
论我国药品审评咨询委员会制度的构建
12.
Discussion on the Revelatory Effects of Canada s CDR System to China;
加拿大的共同药品审评(CDR)制度及对我国的启示
13.
The Necessity of GLP Implementation From Point View of Drug Technical Evaluation;
从药品技术审评的角度看GLP实施的必要性
14.
GSP Interior Appraisal of Request,Procedure and Key in the Drugs Management Enterprise
药品经营企业GSP内部评审的要求、程序及重点
15.
Problem analysis of residual solvents control in drug evaluation
药品审评过程中残留溶剂检查常见问题分析
16.
Guarantee Role of Information Technology in the Drug Technological Evaluation Process
信息技术对我国药品技术审评工作的保障作用
17.
Be responsible for the new item of the equipments and mould; adjust to try, check and acceptance.
负责新增设备设计评审和验收工作。
18.
New Auditing Standards Imrovement of Subsequent Events;
简评新审计准则关于期后事项的改进